SPX3,934.38-29.13 -0.74%
DIA335.37-3.09 -0.91%
IXIC11,004.62-77.39 -0.70%

BRIEF-CSPC Pharmaceutical Says New Indication Application For Marketing Approval Of Mingfule Accepted By NMPA

Reuters · 11/16/2022 05:33
BRIEF-CSPC Pharmaceutical Says New Indication Application For Marketing Approval Of Mingfule Accepted By NMPA

- CSPC Pharmaceutical Group Ltd 1093.HK:

  • NEW INDICATION APPLICATION FOR MARKETING APPROVAL OF MINGFULE OFFICIALLY ACCEPTED BY NMPA

Further company coverage: 1093.HK


((Reuters.Briefs@thomsonreuters.com;))